Qube Research & Technologies Ltd
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 1729829
LONDON, X0
Position in CPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,217,610
-$1,152,120 QoQ
Shares Held
412,666
-15.3% QoQ
Ownership
0.337%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. CPRX ranks #51 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in CPRX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,217,610 | 412,666 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,369,730 | 487,135 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,177,679 | 821,202 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,012,697 | 1,014,410 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,437,178 | 760,296 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,758,589 | 659,252 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,264,731 | 667,240 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,994,089 | 128,734 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,438,585 | 90,250 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $754,916 | 64,578 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $2,266,837 | 121,873 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $859,692 | 122,638 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,274,247 | 153,709 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,207,226 | 178,320 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $447,860 | 84,502 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $254,518 | 44,264 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $130,992 | 34,024 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||